ES490667A0 - Procedimiento para la preparacion de un derivado de 2-hidro-xi-5-(1-hidroxi-2-piperaciniletil)benzoico - Google Patents

Procedimiento para la preparacion de un derivado de 2-hidro-xi-5-(1-hidroxi-2-piperaciniletil)benzoico

Info

Publication number
ES490667A0
ES490667A0 ES490667A ES490667A ES490667A0 ES 490667 A0 ES490667 A0 ES 490667A0 ES 490667 A ES490667 A ES 490667A ES 490667 A ES490667 A ES 490667A ES 490667 A0 ES490667 A0 ES 490667A0
Authority
ES
Spain
Prior art keywords
piperaciniletil
benzoico
hidro
hidroxi
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES490667A
Other languages
English (en)
Other versions
ES8104995A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of ES490667A0 publication Critical patent/ES490667A0/es
Publication of ES8104995A1 publication Critical patent/ES8104995A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES490667A 1979-05-04 1980-04-17 Procedimiento para la preparacion de un derivado de 2-hidro-xi-5-(1-hidroxi-2-piperaciniletil)benzoico Expired ES8104995A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,244 US4255575A (en) 1979-05-04 1979-05-04 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives

Publications (2)

Publication Number Publication Date
ES490667A0 true ES490667A0 (es) 1981-05-16
ES8104995A1 ES8104995A1 (es) 1981-05-16

Family

ID=21887503

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490667A Expired ES8104995A1 (es) 1979-05-04 1980-04-17 Procedimiento para la preparacion de un derivado de 2-hidro-xi-5-(1-hidroxi-2-piperaciniletil)benzoico

Country Status (21)

Country Link
US (1) US4255575A (es)
JP (1) JPS55147262A (es)
AT (1) AT376426B (es)
AU (1) AU531738B2 (es)
BE (1) BE883086A (es)
CA (1) CA1138457A (es)
CH (1) CH645368A5 (es)
DE (1) DE3014813A1 (es)
DK (1) DK159435C (es)
ES (1) ES8104995A1 (es)
FR (1) FR2455590A1 (es)
GB (1) GB2053897B (es)
IE (1) IE49549B1 (es)
IL (1) IL59596A (es)
IT (1) IT1143190B (es)
NL (1) NL8002071A (es)
NO (1) NO152698C (es)
NZ (1) NZ193107A (es)
PH (1) PH17089A (es)
SE (1) SE447109B (es)
ZA (1) ZA801453B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3400168A1 (de) * 1984-01-04 1985-07-11 Bayer Ag, 5090 Leverkusen 5-halogenalkyl-1,3,4-thiadiazol-2-yloxyacetamide
US4616017A (en) * 1984-06-04 1986-10-07 Merck & Co., Inc. Aminohydroxypropoxy substituted aryl compounds
DE3505425A1 (de) * 1985-02-16 1986-08-21 Bayer Ag, 5090 Leverkusen 5-chlor-1,3,4-thiadiazol-2-yloxy-acetamide
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
US4956302A (en) 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
DE3812755A1 (de) * 1988-04-16 1989-10-26 Merck Patent Gmbh Salicylsaeurederivate
KR100484386B1 (ko) * 2000-10-04 2005-04-22 경동제약 주식회사 알킬2-[2,3,5-트리플루오로-4-(4-메틸-1-피페라지닐)]벤조일-3(s)-(1-히드록시프로피-2-닐아미노)아크릴레이트의 제조방법
US20080131954A1 (en) * 2006-11-30 2008-06-05 Canon U.S. Life Sciences, Inc. Method of Separating Target DNA from Mixed DNA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1317479A (en) * 1970-11-10 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
CA1113937A (en) * 1977-04-05 1981-12-08 Frederic P. Hauck Substituted piperidinylpropanols

Also Published As

Publication number Publication date
GB2053897B (en) 1982-10-20
NZ193107A (en) 1982-12-21
NO152698C (no) 1985-11-20
PH17089A (en) 1984-05-29
CH645368A5 (de) 1984-09-28
IT1143190B (it) 1986-10-22
DK159435C (da) 1991-03-25
NL8002071A (nl) 1980-11-06
BE883086A (fr) 1980-09-01
IL59596A0 (en) 1980-06-30
FR2455590A1 (fr) 1980-11-28
SE8003244L (sv) 1980-11-05
ATA232580A (de) 1984-04-15
US4255575A (en) 1981-03-10
JPS55147262A (en) 1980-11-17
CA1138457A (en) 1982-12-28
GB2053897A (en) 1981-02-11
IE49549B1 (en) 1985-10-30
IE800481L (en) 1980-11-04
IL59596A (en) 1984-01-31
IT8048267A0 (it) 1980-03-26
ES8104995A1 (es) 1981-05-16
AT376426B (de) 1984-11-26
NO801297L (no) 1980-11-05
AU5707680A (en) 1980-11-06
SE447109B (sv) 1986-10-27
NO152698B (no) 1985-07-29
DK159435B (da) 1990-10-15
AU531738B2 (en) 1983-09-01
ZA801453B (en) 1980-12-31
DE3014813A1 (de) 1980-11-13
JPS6321666B2 (es) 1988-05-09
DK193680A (da) 1980-11-05
FR2455590B1 (es) 1983-10-14

Similar Documents

Publication Publication Date Title
ES505548A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilaminofluorano
AR222204A1 (es) Un procedimiento para la preparacion de derivados de i-bencilimidazol
ES497640A0 (es) Un procedimiento para la preparacion de derivados de la 7- amino-4-trifluormetilcumarina
ES489752A0 (es) Un procedimiento para la preparacion de un derivado de imi- dazolidindiona
ES501805A0 (es) Un procedimiento para la preparacion de derivados de la eta-nolamina
ES496798A0 (es) Un procedimiento para la preparacion de un derivado de aze- tidina
ES495892A0 (es) Un procedimiento para la preparacion de metacroleina
ES500383A0 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES490510A0 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES489470A0 (es) Un procedimiento para la preparacion de 9-aminoalquilfluore-no
ES491370A0 (es) Un procedimiento para la preparacion de piridizinobenzodiazepinas
ES493506A0 (es) Un procedimiento para la preparacion de desacetil-cefalospo-rina c
ES496487A0 (es) Un procedimiento para la preparacion de nuevos derivados hi-droxialquil-triazoles
ES505555A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES490667A0 (es) Procedimiento para la preparacion de un derivado de 2-hidro-xi-5-(1-hidroxi-2-piperaciniletil)benzoico
ES495865A0 (es) Un procedimiento para la preparacion de derivados de quina- zolina
ES491992A0 (es) Un procedimiento para la preparacion de nuevos derivados de hidroxiamino-eburnano
ES490289A0 (es) Un procedimiento para la preparacion de derivados de xantina
ES490022A0 (es) Un procedimiento para la preparacion de imidazobenzodiacepi-nas
ES494091A0 (es) Un procedimiento para la preparacion de derivados de pirro- lidina
ES495102A0 (es) Un procedimiento para la preparacion de un derivado de iminohalogenuro
AR222208A1 (es) Un procedimiento para la preparacion de derivados de 4-amino-2-piperidino-quinazolina
ES491662A0 (es) Un procedimiento para la preparacion de un pirazol cuaterna-rio
ES489227A0 (es) Un procedimiento para la preparacion de un derivado de pira-zol
ES490287A0 (es) Un procedimiento para la preparacion de 2-aminopirazinas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020304